- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Procept Biorobotics Corp (PRCT)
Track today's live Procept Biorobotics (PRCT) share price, performance and key data on this page with our current NASDAQ:PRCT stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Procept Biorobotics share price on the NASDAQ exchange. Use the dropdown to switch exchange for the PRCT share price, head to our technical summary section, which provides analysis on Procept Biorobotics share price buy/sell indicators using real-time data (or discuss the Procept Biorobotics (PRCT) stock price today with other investors in the Procept Biorobotics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PRCT share price (ISIN: US74276L1052) to enhance your trading decisions with our free investment tools and resources.
What Is the Procept Biorobotics Corp Share Price Today?
The Procept Biorobotics share price today is 18.31.
What Is the Stock Symbol for Procept Biorobotics Corp
The stock symbol (or 'ticker') for Procept Biorobotics Corp is "PRCT."
What Stock Exchange Does Procept Biorobotics Corp Trade On?
Procept Biorobotics Corp is listed and trades on the NASDAQ stock exchange.
Is Procept Biorobotics Corp a Good Stock to Buy?
Determining whether Procept Biorobotics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PRCT share price (ISIN: US74276L1052) to enhance your trading decisions with our free investment tools and resources.
What Is the Procept Biorobotics Corp Share Price Today?
The Procept Biorobotics share price today is 18.31.
What Is the Stock Symbol for Procept Biorobotics Corp
The stock symbol (or 'ticker') for Procept Biorobotics Corp is "PRCT."
What Stock Exchange Does Procept Biorobotics Corp Trade On?
Procept Biorobotics Corp is listed and trades on the NASDAQ stock exchange.
Is Procept Biorobotics Corp a Good Stock to Buy?
Determining whether Procept Biorobotics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
18.31
+0.41(+2.29%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.78
18.44
52 wk Range
16.67
38.11
PRCT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.7818.44
52 wk Range
16.6738.11
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PRCT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
22.42
Upside
+22.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
9 analysts have revised their earnings downwards for the upcoming period
Form 8K Procept Biorobotics Corp For: 24 September- Investing.com
- Form 8K Procept Biorobotics Corp For: 24 September
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
5 Buy
9 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 22.42
(+22.43% Upside)
Procept Biorobotics Corp Earnings Call Summary for Q2/2026
- Q2 revenue rose 19% YoY to $94.5M, beating estimates of $92.76M, but EPS of -$0.47 missed by $0.01; shares fell 4.54% after-hours to $17.45.
- U.S. procedure growth slowed in legacy AquaBeam accounts; company cut full-year U.S. procedure guidance to 54,000-56,000 from prior expectations.
- Full-year revenue guidance maintained at $390M-$410M (27%-33% growth); HYDROS system pricing hit record $495K ASP, showing strong hospital demand.
- Net loss widened to $26.9M from $19.6M YoY; operating expenses jumped to $89.8M from $73.9M as company invests in commercial expansion and R&D.
- Management expects Q4 positive adjusted EBITDA and greater operating leverage in 2027 as R&D spending eases; company holds $231M cash with no debt.
Last Updated: 04/08/2026, 22:48
Read Full TranscriptEarnings
Latest Release
04/08/2026
EPS / Forecast
-0.47 / -0.46
Revenue / Forecast
94.5M / 92.76M
Compare PRCT to Peers and Sector
Metrics to compare | PRCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.5x | −1.3x | −0.3x | |
PEG Ratio | 0.37 | −0.03 | 0.00 | |
Price/Book | 3.1x | 4.8x | 2.6x | |
Price / LTM Sales | 3.1x | 4.0x | 3.0x | |
Upside (Analyst Target) | 26.5% | 77.2% | 62.0% | |
Fair Value Upside | Unlock | 15.1% | 8.2% | Unlock |
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Procept Biorobotics (NASDAQ: PRCT) Share Price Today?
The Procept Biorobotics stock price today is 18.31 USD.
What Stock Exchange Does Procept Biorobotics (PRCT) Trade On?
Procept Biorobotics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Procept Biorobotics?
The stock symbol (also called a 'ticker') for Procept Biorobotics is "PRCT."
What Is the Current Procept Biorobotics Market Capitalisation?
As of today, Procept Biorobotics (NASDAQ: PRCT) market cap is 1.03B USD.
What Is Procept Biorobotics's (PRCT) Earnings Per Share (TTM)?
The Procept Biorobotics EPS is currently -1.95 (Trailing Twelve Months).
When Is the Next Procept Biorobotics Earnings Date?
Procept Biorobotics's next earnings report will be released on 29/10/2026.
Is PRCT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Procept Biorobotics moving averages and other technical indicators, the daily buy/sell signal for PRCT stock is Neutral.
How Many Times Has Procept Biorobotics Stock Split?
Procept Biorobotics has split 0 times. (See the PRCT stock split history page for full effective split date and price information.)
How Many Employees Does Procept Biorobotics Have?
Procept Biorobotics has 888 employees, based on their latest Companies House report.
What is the current trading status of Procept Biorobotics (NASDAQ: PRCT)?
As of 09/10/2026, Procept Biorobotics (PRCT) is trading at a share price of 18.31 USD, with a previous close of 17.90 USD. The stock has fluctuated within a day range of 17.78 USD to 18.44 USD, while its 52-week range spans from 16.67 USD to 38.11 USD.
What Is Procept Biorobotics (PRCT) Price Target According to Analysts?
The average 12-month price target for Procept Biorobotics is 22.42 USD, with a high estimate of 30 USD and a low estimate of 16 USD. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +22.43% Upside potential.
What Is the PRCT Premarket Price?
PRCT's last pre-market stock price is 17.85 USD. The pre-market share volume is 690.00, and the stock has decreased by -0.05, or -0.28%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.